H&Q Life Sciences Investors
,
Web Site: http://www.hqcm.com
| H&Q Life Sciences Investors operates as a diversified closed-end management investment company. It primarily invests in securities of companies in the healthcare industry. The company's portfolio comprises investments primarily in biopharmaceuticals, drug delivery, drug discovery technologies, emerging biopharmaceuticals, generic pharmaceuticals, healthcare services, and medical devices and diagnostics sectors. Hambrecht & Quist Capital Management, LLC serves as the investment advisor of the company. H&Q Life Sciences was founded in 1992 and is based in Boston, Massachusetts. |
|
| Key Statistics |
|
|
|
| |
Pay |
Exercised |
Dr. Daniel R. Omstead Ph.D., 54
Principal Exec. Officer, Pres, Trustee, Chief Exec. Officer of Hambrecht & Quist Capital Management Inc-the Adviser and Pres of Hambrecht & Quist Capital Management Inc -the Adviser
|
$
0 |
N/A |
Ms. Kathleen M. Eckert , 42
Principal Financial Officer
|
N/A
|
N/A |
Mr. Christopher F. Brinzey ,
Sr. VP of Research - Investment Adviser
|
N/A
|
N/A |
Ms. Carolyn P. Haley CPA, 41
Chief Compliance Officer, Sec. and Treasurer
|
N/A
|
N/A |
Dr. Frank T. Gentile Ph.D., 46
Sr. VP of Research - Investment Adviser
|
N/A
|
N/A |
|
|
|
Dollar amounts are as of
31-Dec-06
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
|
|
|
Help
Profile
